Carregando empresa
Just reported
Q2 FY2027 results
From Doximity's results release of 5 de novembro de 2026; its quarterly report has since been filed.
Revenue
Actual
US$ 174,5M
+3,6% y/y
+11% q/qGuided
US$ 170,5M
midpoint
Above guide+2,4%EPS, GAAP
Actual
US$ 0,18
-42% y/y
+38% q/qGuided
—
No guide given
EPS, adjusted: US$ 0,36
Operating income, GAAP
Actual
US$ 43,9M
-31% y/y
+31% q/qGuided
—
No guide given
Company outlook
Q3 FY2027
- RevenueUS$ 195M – US$ 196M+5,6% y/y First given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Doximity is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Health Information Services
Graded A or B and worth $2B or more: A first, then the largest.
VEEVVeeva Systems Inc.US$ 49,4BA+
BTSGBrightSpring Health Services, Inc.US$ 14,4BA
HNGEHinge Health, Inc.US$ 9,9BA+
HQYHealthequity, Inc.US$ 8,5BA+
WAYWaystar Holding Corp.US$ 5,5BB+
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 de out. de 2026CBGraded C, now B
MCKMckesson Corporation4 de nov. de 2026BAGraded B, now A
CVSCVS Health Corp4 de nov. de 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 de nov. de 2026BAGraded B, now A
BIIBBiogen Inc.28 de out. de 2026BAGraded B, now A
Demonstrações financeiras completas →
Construído a partir dos próprios documentos de Doximity, Inc. entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
